Adoptive cell therapy (ACT) is an immunotherapy that employs living immune cells to target and destroy cancer cells. However, the inhibitory tumor microenvironment features several obstacles to ...
Comprehensive genomic profiling (CGP) of clinically advanced and metastatic cutaneous adnexal carcinomas (CAs; MCADCA): A genomic landscape study. This is an ASCO Meeting Abstract from the 2023 ASCO ...
Effect of the killing style of individual CAR T cells on the clinicopathological behavior of therapeutic products in the clinic. Initial results from a first in human dose escalation trial of a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results